HELSINKI--(BUSINESS WIRE)--MediSapiens, a leading Finnish developer and provider of genomic and healthcare data solutions, extends is solution delivery network by offering its Explorer™ Platform based genomic, clinical and biomedical data curation, management and analytics solutions in Microsoft’s Azure Cloud. The first stage target customers on Azure hosted solutions are Finnish healthcare facilities and institutions, while the partnership reinforces the global reach for MediSapiens solutions.
The Explorer™ Platform comprises scalable tools for small and big clinical, genomic and biomedical data curation, management and analytics. The tools are built to ensure that the rapidly growing data amounts, generated by healthcare facilities and their partners, are curated to a harmonized, integrated and quality-assured format, and can thus be reliably and efficiently used for data-driven research for personalized medicine development and other scientific and healthcare purposes.
“Microsoft is a prominent cloud platform provider for healthcare. Microsoft’s focus on data security and regulatory compliance are perfectly matched with MediSapiens’ endeavors on bringing world class genomic, clinical and biomedical big data solutions to benefit healthcare facilities and clinical research not only in Finland but globally”, says Marko Kuisma, Chief Commercial Officer of MediSapiens. “We’re very excited about the partnership. Our collaboration with Microsoft means that many healthcare facilities will be able to implement MediSapiens’ data solutions to their existing IT infrastructure. Customers will be able to run heavy-duty genomic and clinical data analytics, but the data will never need to exit the customer’s firewalls.”
Microsoft’s Azure Cloud solutions are used by healthcare facilities worldwide. Microsoft follows its strategy to partner with companies on the healthcare application layer, while providing secure cloud infrastructures for its customers.
“We are very pleased to have innovative partners like MediSapiens to provide world class services using our technology”, says Matti Antila, Partner Business and Development Lead of Microsoft Finland. “Having genomic data interpretation solutions on Microsoft Azure jointly with MediSapiens is a step forward in using the best technology available for improved healthcare services. We are living in an exciting era where we can learn so much from increasing amounts of genomic, clinical and biomedical data through efficient data interpretation and analytics solutions. Partnering with MediSapiens opens up opportunities for new methods and practices for personalized medicine, paving the way for better treatments. Thanks to Microsoft Azure’s ubiquitous nature, together we can serve customers locally and globally in a safe and fast paced mobile first, cloud first world.”
MediSapiens continues to offer its solutions on several delivery platforms: client hosted, MediSapiens server cluster hosted and private and commercial cloud hosted options.
About MediSapiens
MediSapiens Ltd. is a Bio-IT and bioinformatics company specialized in pharmaceutical research and translational genomics, providing life science and biomedical companies and research organizations with tools that help them manage and interpret large genomic, biomedical and clinical data sets. Established in 2009 and based in Helsinki, Finland and Cambridge, Massachusetts, MediSapiens creates intuitive software platforms to manage, integrate, and visualize complex multi-dimensional datasets, such as genomic sequencing data. The company's goal is to drive medicine forward by developing tools that provide scientists with a way to quickly analyze and visualize vast amounts of data and turn it into knowledge that fuels innovation. For further information, please visit http://www.medisapiens.com.
This information was brought to you by Cision http://news.cision.com